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Abstract
Highly pathogenic avian influenza virus (HPAIV) of the subtype H5N1 causes severe, often fatal pneumonia in humans. The
pathogenesis of HPAIV H5N1 infection is not completely understood, although the alveolar macrophage (AM) is thought to
play an important role. HPAIV H5N1 infection of macrophages cultured from monocytes leads to high percentages of
infection accompanied by virus production and an excessive pro-inflammatory immune response. However, macrophages
cultured from monocytes are different from AM, both in phenotype and in response to seasonal influenza virus infection.
Consequently, it remains unclear whether the results of studies with macrophages cultured from monocytes are valid for
AM. Therefore we infected AM and for comparison macrophages cultured from monocytes with seasonal H3N2 virus, HPAIV
H5N1 or pandemic H1N1 virus, and determined the percentage of cells infected, virus production and induction of TNF-
alpha, a pro-inflammatory cytokine. In vitro HPAIV H5N1 infection of AM compared to that of macrophages cultured from
monocytes resulted in a lower percentage of infected cells (up to 25% vs up to 84%), lower virus production and lower TNF-
alpha induction. In vitro infection of AM with H3N2 or H1N1 virus resulted in even lower percentages of infected cells (up to
7%) than with HPAIV H5N1, while virus production and TNF-alpha induction were comparable. In conclusion, this study
reveals that macrophages cultured from monocytes are not a good model to study the interaction between AM and these
influenza virus strains. Furthermore, the interaction between HPAIV H5N1 and AM could contribute to the pathogenicity of
this virus in humans, due to the relative high percentage of infected cells rather than virus production or an excessive TNF-
alpha induction.
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Introduction
Seasonal, pandemic and zoonotic influenza A virus infections
cause substantial morbidity and mortality in humans. Seasonal
influenza virus infections in humans are usually mild, causing
pneumonia in a minority of infected individuals. Pandemic
influenza virus infections vary in their disease outcome. The
1918 Spanish flu caused pneumonia more often than the recent
pandemic H1N1 (pH1N1) virus. Zoonotic influenza virus
infections in humans vary from self-limiting conjunctivitis to
severe, often fatal pneumonia. The currently ongoing outbreak of
highly pathogenic avian influenza virus (HPAIV) of the subtype
H5N1 in poultry is sporadically transmitted to humans, in which it
causes severe pneumonia with a case-fatality rate of about 60%
[1,2,3].
The differences in pathogenesis of different influenza virus
infections in humans, and thereby their disease outcome are only
partly understood. Early events after infection of the human
alveoli—the site of pneumonia—contribute to protection against
or the development of pneumonia. Previously we have shown that
different influenza viruses attach to different cell types in the
human alveoli. Seasonal influenza viruses and pH1N1 virus attach
predominantly to type I pneumocytes [4,5], whereas HPAIV
H5N1 attaches predominantly to type II pneumocytes and
alveolar macrophages (AM) [6]. This fits with the detection of
influenza A virus antigens in type II pneumocytes in lung tissues
from HPAIV H5N1 fatal infections [7,8,2]. Furthermore, in
experimental HPAIV H5N1 infections of ex vivo lung cultures,
influenza virus antigen was detected in type II pneumocytes and
alveolar macrophages [9,10]. Therefore, the response of alveolar
epithelial cells and AM early after HPAIV H5N1 infection is likely
important in the development of disease. In the present study we
focus on the AM, an important cell of the innate immune system
in the human alveolus.
Lung macrophages can be distinguished in alveolar, pleural,
interstitial and intravascular macrophages, but the AM is the most
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[11]. The phenotype of the AM is induced by the micro-
environment of the human alveoli, which includes interactions
with epithelial cells, the presence of surfactant proteins A (SP-A)
and D (SP-D) and the presence granulocyte-macrophage colony
stimulating factor (GM-CSF) [12,13]. This phenotype resembles
that of alternatively activated macrophages or deactivated
macrophages, which were first described in 1992 [14,15,16,17].
Precursors of AM are monocytes that enter the lung [11], after
which they mature into the AM phenotype [18].
The AM has a protective role in the lung to prevent loss of
function. Therefore, immune responses need to be balanced to
protect the lungs from invading pathogens without excessive
inflammation [18]. AM phagocytose virus particles and apoptotic
cells by which they protect the lung from influenza induced
damage [19,20]. Depletion of AM leads therefore to enhanced
virus replication and more severe disease during influenza virus
infection [21,22].
The role of the AM in the pathogenesis of HPAIV H5N1-
induced pneumonia has been studied by in vitro infections of
macrophages cultured from monocytes in the presence of human
serum (MM). In MM, HPAIV H5N1 infects up to 100% of the
cells, which results in a productive infection. Infection of MM with
HPAIV H5N1 also results in an excessive immune response,
marked by the high induction of the pro-inflammatory cytokine
TNF-alpha, which is not observed after infection with seasonal
H1N1 or H3N2 virus [23,24,25]. However, AM and MM are
phenotypically different cells, where AM have a alternatively
activated phenotype, whereas MM have a classical activated
phenotype [15]. Furthermore, MM respond differently to
influenza virus infections than AM as was shown by Ettensohn
and Roberts [26]. In that study, MM produced significantly higher
levels of interferon than AM. Another study revealed that only up
to 20% of AM were infected with seasonal influenza viruses, and
did not result in a productive infection [27]. Therefore, it is
unclear whether MM are suitable substitutes for studying the
interaction between influenza virus and AM.
To address this question, we compared the effect of seasonal
H3N2 virus, pH1N1 virus or HPAIV H5N1 infection both on AM
from broncho-alveolar lavages (BAL) of healthy volunteers, and on
MM. In addition, we determined the percentage of AM infected in
experimentally infected ex vivo cultured lung biopsies. Also we
examined whether monocytes cultured in the presence of GM-
CSF (GM-MM)—which is abundantly present in the alveolar
lining fluid—instead of human serum would develop a phenotype
more similar to that of the AM [28].
Results
Percentage of cells infected in ex vivo lung biopsies
All three viruses, seasonal H3N2 virus, pH1N1 virus and
HPAIV H5N1, infected AM in experimentally infected ex vivo lung
cultures, although percentages varied largely. In the double-
staining, influenza virus antigen was present in the nucleus,
indicative for virus replication, whereas HAM65, a macrophage
marker, was present in the cytoplasm (Figure 1a–c). HPAIV H5N1
infected significantly more AM than seasonal H3N2 or pH1N1
viruses in ex vivo cultured lung biopsies (Figure 1d).
Phenotype of macrophages
AM had a round shape (Figure 2a). The shape of macrophages
cultured from monocytes depended on the culture medium in
which they differentiated. Most MM (cultured in the presence of
human serum) were spindle-shaped with a few round cells
(Figure 2b); in contrast, most GM-MM (cultured in the presence
of GM-CSF) were round with a few spindle-shaped cells
(Figure 2c). All cells were confirmed to be of the macrophage/
monocyte lineage by CD68 staining (Figure 2a–c).
Percentage of AM, MM and GM-MM infected
Influenza A antigen was visible as nuclear and cytoplasmic red
staining (Figure 2d–f). Significant less AM than MM from the
same donor were infected with either seasonal H3N2 virus or
HPAIV H5N1 (Figure 3a). The percentage of AM infected by
influenza virus declined significantly in the following order:
HPAIV H5N1 . seasonal H3N2 virus . pH1N1 virus
(Figure 3a). The same pattern was observed for MM and GM-
MM (Figure 3b) cultured from the blood bank donors. For each of
the three viruses tested, the percentage of cells infected did not
differ significantly between MM cultured from the BAL- and
blood bank donors, or between the MM and GM-MM from the
blood bank donors (Figure 3a–b).
Virus production in AM, MM and GM-MM
There was no significant influenza virus production in AM
regardless of the virus used (Figure 4a). In contrast, there was
significant production of seasonal H3N2 virus and HPAIV H5N1
in both MM and GM-MM (Figure 4b and 4c). There was no
significant pH1N1 virus production in any of the cell types used.
Cytokine production in AM and MM after virus
inoculation or LPS exposure
HPAIV H5N1 infection of AM did not induce significant more
TNF-alpha mRNA levels than seasonal H3N2 virus or pH1N1
virus 8 and 24 hpi (Figure 5a and 5b). In contrast, and as found
previously [23], this was the case for HPAIV H5N1 virus infection
of MM. There was a trend (p=0.055) for HPAIV H5N1 infection
to induce more TNF-alpha in MM than AM, both at 8 and 24 hpi
(Figure 5a and 5b). The results for TGF-beta were similar for those
of TNF-alpha, although overall the levels of induction were lower:
HPAIV H5N1 infection did not induce significantly more TGF-
beta than seasonal H3N2 virus or pH1N1 virus in AM, but did in
MM (Figure 5c and 5d). Interestingly, pH1N1 virus infection of
MM induced significantly more TGF-beta than that of AM, both
Author Summary
Alveolar macrophages (AM), which reside in the alveolar
lumen, usually dampen down the host immune response
to incoming pathogens. However, they are thought to
increase inflammation during highly pathogenic avian
influenza virus (HPAIV) H5N1 infections, which cause
severe and often fatal disease in humans. This is based
on experiments with human macrophages cultured from
monocytes rather than with human AM. Here we show
that human AM, collected via broncho-alveolar lavage
from healthy volunteers, can become infected with HPAIV
H5N1. However, this results in neither induction of the pro-
inflammatory cytokine TNF-alpha nor virus production.
Therefore, AM are most likely not responsible for the
excessive cytokine response or high viral load during
human HPAIV H5N1 infections as assumed previously.
These data significantly changes our insight into the
pathogenesis of HPAIV H5N1 pneumonia in humans,
indicating that other cells than AM must be responsible
for the excessive pro-inflammatory cytokine profile ob-
served during HPAIV H5N1 infections.
Influenza Virus Infection in Alveolar Macrophages
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replication in MM, this induction might be a response of
phagocytosis of virus proteins only.
After exposure to LPS, there was significantly more TNF-alpha
induced in MM than AM 8 hpi. Although this trend was still
present 24 hpi, this difference was no longer significant at 24 hpi
(p=0.06) (Figure 6). This inhibition of TNF-alpha induction in
AM is indicative for the alternative activation phenotype, in
contrast to the classical activation phenotype of MM.
Discussion
This is the first time that the role of AM during HPAIV H5N1
virus infection has been studied. This study shows that AM are
more susceptible to HPAIV H5N1 infection than to seasonal
H3N2 or pH1N1 virus infection but, that this infection results
neither in virus production nor in an excessive immune response.
Macrophages cultured from monocytes do not respond the
same way as AM to two out of three influenza viruses included in
this study: there are significant differences between MM and AM
in the percentages of cells infected, cytokine response and virus
production after infection with HPAIV H5N1 and seasonal H3N2
virus. Therefore, MM are not suitable to study the interaction
between AM and these influenza virus strains.
HPAIV H5N1 infected more AM than seasonal H3N2 or
pH1N1 viruses, in both the ex vivo lung cultures and in AM
collected from BAL. This fits with the results of our virus
attachment studies, in which HPAIV H5N1 attached more
abundantly to AM than H3N2 virus [4] and pH1N1 [5]. Infection
of an AM likely hampers its protective function and, since
approximately one AM is found in each alveolus [11], this could
lead to substantial loss of protection in the alveoli.
HPAIV H5N1 infection in AM did not result in significantly
higher induction of TNF-alpha mRNA compared to seasonal
H3N2 or pH1N1 virus. This is in contrast with the significantly
higher TNF-alpha mRNA levels in MM after HPAIV H5N1 virus
infection compared to seasonal H3N2 and pH1N1 virus infection
observed in our and previous studies [23,24,25]. The observed
difference in TNF-alpha induction can likely be explained by the
activation phenotype of AM compared to that of MM. MM
represent classical activated macrophages, while AM are alterna-
tive activated or deactivated macrophages. LPS is known to induce
TNF-alpha production in classically activated macrophages but
not in alternatively activated macrophages [29,17,16]. The
inhibited TNF-alpha induction of AM in this study fits with their
alternatively activated phenotype. This inhibition of TNF-alpha
induction in alternatively activated macrophages is thought to be
regulated by the p50 subunit of NF-kB [30].
TNF-alpha, and the cascade it induces, is known to attract
neutrophils and other leukocytes in the lung and is thought to play
Figure 1. Alveolar macrophages in ex vivo lung cultures. Double
staining for influenza A virus nucleoprotein (brown nuclear staining)
and a macrophage marker (red/pink, cytoplasmic staining) 24 hours
after infection with seasonal H3N2 virus (a), HPAIV H5N1 virus (b) or
pandemic H1N1 virus (c). The arrowhead indicates influenza virus
staining in alveolar epithelial cells and the arrow indicates an alveolar
macrophage (AM). Seasonal H3N2 virus infection results in infection of
alveolar epithelial cells (arrowhead) but not of AM (arrow). HPAIV H5N1
infection results in the infection of alveolar epithelial cells (arrowhead)
and infection of AM (arrow). Pandemic H1N1 virus infection results in
infection of alveolar epithelial cells (arrowhead) but not of AM (arrow).
Percentages of AM infected after 24 hpi with seasonal H3N2 virus,
HPAIV H5N1 or pH1N1 virus infection (d). Mean values are represented
by horizontal lines. * indicates a statistical (p,0.05) difference.
doi:10.1371/journal.ppat.1002099.g001
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syndrome and multiple organ dysfunction syndrome [31]. The
lack of excessive TNF-alpha induction in AM after infection with
the HPAIV H5N1 strain used in this study might indicate that, in
contrast to previous conclusions based on studies with MM, the
AM does not contribute to the excessive immune response after
HPAIV H5N1 infections.
The lack of virus production in AM after infection with
influenza viruses included in this study corresponds with a
previous study in which no virus release in AM was detected
after infection with a seasonal H1N1 or H3N2 virus [27]. The lack
of significant virus production indicates that AM do not release
high numbers of new virus particles and thereby do not contribute
to a productive infection in the human alveolus.
During influenza virus pneumonia, there is an influx of a variety
of leukocytes, including monocytes [1]. The monocytes that enter
the alveoli during influenza virus pneumonia most likely respond
differently than resident AM. We cannot exclude that these
monocytes will respond in a similar way as MM, with high
percentages of cells infected, a productive infection and the
Figure 2. CD68 and influenza A virus antigen expression in alveolar macrophages and macrophages cultured from monocytes.
Macrophages included were alveolar macrophages (a, d), macrophages cultured from monocytes in the presence of human serum (b, e), and
macrophages cultured from monocytes in the presence of GM-CSF (c, f). In uninfected cells, staining for CD68 (a–c) confirms that these cells were of
the monocyte/macrophage lineage. Twenty-four hours after infection with HPAIV H5N1, staining for influenza A virus nucleoprotein (d–f) confirms
that these cells were infected by influenza virus.
doi:10.1371/journal.ppat.1002099.g002
Figure 3. Percentage of alveolar macrophages and monocyte-derived macrophages infected with H3N2, H5N1 or H1N1 virus.
Percentage of infected alveolar macrophages (AM) and monocyte-derived macrophages cultured in the presence of human serum (MM), from the
same donor (a). Percentages of infected MM or macrophages cultured in the presence of GM-CSF (GM-MM), cultured from the same blood bank
donors (b). Mean values are represented by horizontal lines. * indicates a statistical (p,.05) difference.
doi:10.1371/journal.ppat.1002099.g003
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monocytes and influenza virus has never been studied, so their role
remains to be elucidated.
Interestingly, macrophages that were cultured in the presence of
GM-CSF, resembled AM in shape, but differed in their response
to influenza virus infection. In fact, the percentages of cells infected
of GM-MM resembled that of the MM more closely. Although
GM-CSF is abundantly present in the human alveolus and is
thought to be responsible for the AM phenotype [32,33,28],
addition of GM-CSF was not sufficient to transform the phenotype
of monocytes to that of AM, with respect to their response to
influenza virus infections. It is likely that other factors present in
the alveolus are required for this transformation.
Overall, the pH1N1 virus used in this study did not infect high
percentages of either AM or MM. Even compared to seasonal
H3N2 virus, pH1N1 virus infected lower percentages of cells.
Whether this is a unique feature of pH1N1 virus or a common
feature of pandemic influenza viruses remains to be determined.
Overall, this observation fits with the relatively mild disease caused
by pH1N1 virus infection [34].
Figure 4. Virus production in alveolar macrophages and monocyte-derived macrophages after H3N2, H5N1 or H1N1 virus
infection. Virus production of alveolar macrophages (AM) (a), macrophages cultured in the presence of human serum (MM) (b), and macrophages
cultured in the presence of GM-CSF (GM-MM) (c), after infection with seasonal H3N2 virus, HPAIV H5N1 or pandemic H1N1 virus. Geometric mean
titers were calculated from independent experiments; error bars indicate standard deviation. * indicates a statistical (p,0.05) difference. ** indicates a
statistical (p,0.01) difference.
doi:10.1371/journal.ppat.1002099.g004
Figure 5. Cytokine mRNA levels after H3N2, H5N1 or H1N1 virus infection. TNF-alpha mRNA levels expressed in fold-induction over non-
infected cells after seasonal H3N2 virus, HPAIV H5N1 or pandemic H1N1 virus infection in alveolar macrophages (AM) and macrophages cultured in
the presence of human serum (MM) at 8 hpi (a) and 24 hpi (b). The same for TGF-beta mRNA levels at 8 hpi (c) and 24 hpi (d). Mean values are
represented by horizontal lines. * indicates a statistical (p,0.05) difference.
doi:10.1371/journal.ppat.1002099.g005
Influenza Virus Infection in Alveolar Macrophages
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study the interaction between AM and these influenza virus
strains, which might be due to their difference in phenotype;
alternatively activated versus classically activated. In contrast to
MM, AM do not induce excessive TNF-alpha after HPAIV H5N1
infection. However, AM are more abundantly infected by HPAIV
H5N1 than by seasonal H3N2 virus or pH1N1 virus. We speculate
that this relatively high percentage of AM infection by HPAIV
H5N1 may contribute to the unusual high pathogenicity of
HPAIV H5N1 for the human lung.
Materials and Methods
Ethics statement
The collection of AM via a broncho-alveolar lavage was
approved by the Dutch Medical Ethical Committee (METC
Erasmus MC, Rotterdam, The Netherlands, MEC-2008-018). All
study participants provided written informed consent for the
collection of samples and subsequent analysis.
Viruses
Viruses used for these experiments were seasonal H3N2 virus
(A/Netherlands/213/03), a pandemic H1N1 virus (A/NL/602/
09) and a HPAIV H5N1 (A /Vietnam/1194/04). All virus stocks
were prepared on Madin-Darby Canine Kidney cells (MDCK).
Percentage of AM infected in ex vivo lung cultures
Surgically removed lung tissues, without any histological
evidence for respiratory disease, were used for ex vivo infections.
Biopsies were made with a 3-mm-biopsy punch and cultured
overnight in F12K (Gibco, Breda, The Netherlands) supplemented
with 100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM
glutamine and 5% FCS. After washing, to remove FCS, lung
biopsies were infected with 10
7 tissue culture infectious dose
(TCID)50/ml of seasonal H3N2 virus, pH1N1 virus or HPAIV
H5N1 at room temperature on a rocker for 1 hour. Lung biopsies
were washed and cultured in F12K supplemented with 100 U/ml
penicillin, 100 mg/ml streptomycin and 2 mM glutamine at 37uC
in 95% O2 and 5% CO2. After 24 hours, biopsies were collected
in 10% neutral-buffered formalin, embedded in paraffin, and
sectioned at 3 mm.
All lung biopsy sections were stained for pancytokeratin to
determine the condition of the alveolar epithelium. Lung biopsy
sections of which the epithelium in more than 50% of the alveoli
was desquamated were excluded. Lung biopsy sections infected
with seasonal H3N2 virus (n=5) pH1N1 virus (n=3), HPAIV
H5N1 (n=6), or uninfected lung biopsy sections were stained for
influenza A virus nucleoprotein as described earlier [35]. To
determine the percentage of AM infected, sections were double-
stained for influenza A virus nucleoprotein and HAM65
(macrophage marker). Slides were incubated with an antibody
against influenza A virus nucleoprotein (IgG2a, Clone Hb65,
American Type Culture Collection, Wesel, Germany), followed by
incubation with an antibody against HAM65 (IgM, DAKO,
Glostrup, Denmark). Primary antibodies were detected with a
mixture of peroxidase-labeled goat-anti-mouse IgG2a (Southern
Biotech, Birmingham, AL, USA) and alkaline phosphatase-labeled
goat-anti-mouse IgM (Southern Biotech). Peroxidase activity was
revealed with 3,39–diaminobenzidine-tetrachlorhydrate (DAB)
(Sigma, St. Louis, MO, USA), resulting in a brown precipitate.
Alkaline phosphatase was revealed with fast red TR/naphthol AS-
MX (Sigma), resulting in a pink precipitate. All macrophages
present in the alveolar lumina were counted as influenza A positive
or -negative. The number of AM present in the lung biopsy
sections varied between 36 and 223 per section. In total 684 AM
were counted in H3N2-infected lung biopsy sections, 741 AM in
HPAIV-H5N1-infected lung biopsy sections and 590 AM in
pH1N1-infected lung biopsy sections.
Isolation and culture of alveolar macrophages
Six non-smoking volunteers (age .18 years) free of any
respiratory symptoms, with a normal lung function (FEV1
.85% predicted, Tiffeneau-index .0.7), and a normal thorax
X-ray underwent a BAL. The BAL was performed according to
standard clinical procedures. A total of 3 times 50 ml warm, sterile
0.9% NaCl was instilled and aspirated sequentially. The middle
pulmonary lobe was selected for sampling in all cases.
From each donor, the BAL was filtered to remove debris and
mucus. Subsequently, AM from each donor were independently
plated in the required concentrations in serum-free macrophage
medium (SFM, Gibco) supplemented with 100 U/ml penicillin,
100 mg/ml streptomycin and 2 mM glutamine. After 2 hours,
non-adherent cells were removed. To confirm that cells isolated
were macrophages, cells were stained for CD68 (KP-1, Dako)
using the same protocol as for the influenza nucleoprotein staining
described below.
Culture of monocyte-derived macrophages from
heparine blood
From each donor that underwent the BAL, peripheral blood
mononuclear cells (PBMC) were isolated from heparinized blood
using a Lymphoprep gradient (density 1.00760.001 g/ml (Axis-
shield PoC AS)). Subsequently, monocytes were purified using a
Percoll gradient (density 1.06360.002 g/ml (GE healthcare,
London, UK)). Monocytes from each donor were cultured in
suspension at a concentration of 1*10
6 cells/ml in teflon flasks
(Nalgene, Roskilde, Denmark) in RPMI-1640 (Lonza, Walkers-
ville, MD, USA) supplemented with 100 U/ml penicillin, 100 mg/
ml streptomycin, 2 mM glutamine and 5% human AB serum.
After 7 days, monocyte-derived macrophages (MM) from each
donor were harvested from the teflon flask and seeded indepen-
dently in flat-bottom culture plates. After 2 hours, non-adherent
Figure 6. TNF-alpha mRNA levels in alveolar macrophages and
monocyte-derived macrophages after LPS exposure. TNF-alpha
mRNA levels expressed in fold-induction over non-infected cells after
LPS exposure of alveolar macrophages (AM) or monocyte-derived
macrophages (MM) at 8 hpi and 24 hpi. Mean values are represented
by horizontal lines. * indicates a statistical (p,0.05) difference.
doi:10.1371/journal.ppat.1002099.g006
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below.
Culture of monocyte-derived macrophages from blood
bank donors
Blood was diluted in PBS and centrifuged for 10 minutes at
220 g. The top layer, mainly consisting of thrombocytes, was
discarded. After this extra procedure, PBMC and monocytes were
subsequently isolated and purified as described above. For
comparison, from each blood bank donor, half of the monocytes
were cultured in teflon flasks as described above, and the other half
was cultured in RPMI supplemented with 100 U/ml penicillin,
100 mg/ml streptomycin, 2 mM glutamine, 5% FCS and GM-
CSF (25 ng/ml, Invitrogen, Paisley, UK). GM-CSF cultured MM
(GM-MM) were harvested after 7 days. Cells were stained for
CD68 as described below.
Percentage of cells infected
AM (n=6), MM (n=10, 6 paired samples with AM and 4 from
blood bank donors) and GM-MM (n=4) were seeded in a
concentration of 50 000 cells per wells. MM obtained from
peripheral blood of the AM donors were compared directly to AM
from the same donor in below infection experiments. Cells were
infected with a multiplicity of infection (MOI) of 2 with seasonal
H3N2 virus, pH1N1 virus or HPAIV H5N1 for 1 hour. After
8 hours post infection (hpi), cells were fixed in the plate with 80%
acetone and stored at 220uC. Plates were thawed, and washed
with PBS before incubation with the primary antibody, a mouse-
anti-influenza A nucleoprotein (Hb65) followed by peroxidase-
labeled goat-anti-mouse IgG2a. Peroxidase was revealed using
AEC resulting in a red precipitate. Influenza virus positive and -
negative cells were counted in five 40x high power fields.
Virus production
AM (n=6), MM (n=6) and GM-MM (n=4) were seeded in a
concentration of 100 000 cells per well and infected with a MOI of
0.1 with seasonal H3N2 virus, pH1N1 virus or HPAIV H5N1 for
1 hour. Supernatants were sampled at 4, 8 and 24 hpi. Virus
titrations on these supernatants were performed by end-point
titration in MDCK cells as described previously [36].
Cytokine production after virus inoculation or LPS
exposure
AM (n=6 per treatment) and MM (n=6 per treatment) were
seeded in a concentration of 100 000 cells per well and infected
with an MOI of 2 with seasonal H3N2 virus, pH1N1 virus or
HPAIV H5N1 for 1 hour, or exposed to 100 ng/ml LPS for
1 hour. At 8 and 24 hpi, cells were harvested in lysis buffer, and
mRNA was isolated using an mRNA capture kit (Roche
Diagnostics Netherlands, Almere, Netherlands) according to
manufacturer’s instructions. Subsequently, cDNA was made using
Superscript III reverse transcriptase (Invitrogen). Taqman analysis
was used to determine target gene RNA expression as described
previously [37]. Gene expression levels were corrected for
GAPDH mRNA and ubiquitin C (UBC) mRNA levels and PCR
efficiency, and expressed in fold induction (FI) over uninfected
cells sampled at the same time point. Sequences of the PCR
primers (Eurogentec, Maastricht, The Netherlands) are: forward
primer 59-TCCACTGGCGTCTTCAC, reverse primer 59-GGC-
AGAGATGATGACCCTTTT for GAPDH; forward primer 59-
GGCAAAGATCCAAGATAAGGAA, reverse primer 59-GGAC-
CAAGTGCAGAGTGGAC for UBC; forward primer 59-GAGC-
CCAAGGGCTACCAT, reverse primer 59-GGGTTATGCTG-
GTTGTACAGG for TGF-beta; forward primer 59-CAGCCT-
CTTCTCCTTCCTGAT, reverse primer 59-GCCAGAGGGC-
TGATTAGAGA for TNF-alpha. Probes from the universal probe
library from Roche were used; probe 45 for GAPDH; probe 11 for
UBC; probe 29 for TNF-alpha and TGF-beta.
Statistics
Statistical analyses were performed using SPSS 15 software.
The Wilcoxon test was used for analysis of paired samples, and the
Mann-Whitney test for unpaired samples.
Accession numbers
TNF-alpha – NM_000594.2 (NCBI); TGF-beta – NM_000660.3
(NCBI); GAPDH – NM_002046.3 (NCBI) and UBC –
NM_021009.4 (NCBI).
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